Screener
Gain Therapeutics GANX Q1 2025 earnings
Reported May 14, 2025 · Before market open
EPS-$0.16In line
Revenue estimate$25.0K
EPS estimate-$0.16
Next report
Nov 11, 2026 (in 2 months)Revenue estimate$33.3K
EPS estimate-$0.13
Versus estimates
Diluted EPS
FAQ
- When did Gain Therapeutics report Q1 2025 earnings?
- Gain Therapeutics (GANX) reported Q1 2025 earnings on May 14, 2025 before market open.
- What were Gain Therapeutics's Q1 2025 revenue and EPS?
- Gain Therapeutics reported eps of $-0.16 for Q1 2025.
- Did Gain Therapeutics beat estimates in Q1 2025?
- EPS beat the consensus estimate of $-0.16 by $0.00.
- How did Gain Therapeutics's Q1 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 27.3% from $-0.22.
- Where can I find Gain Therapeutics's Q1 2025 SEC filings?
- You can read the 8-K earnings release (0001558370-25-007744) and the 10-Q periodic report (0001558370-25-007747) directly on SEC EDGAR. The filing index links above go to sec.gov.
